Andy Yates: Taking cannabis down from the high to solve unmet medical needs
Send us Fan Mail
Sam and Ivanna speak to Andy Yates, the Chief Scientific Officer for Artelo Biosciences about how they are tapping into the potential of the endocannabinoid system to increase treatment results for oncology patients.
Artelo Biosciences has departed from the cannabis plant as the single source of cannabinoids to target specific parts of the endocannabinoid system, and separate the effect on the body from the brain. “You cannot get high off our drug,” Andy Yates says.
Using the natural appetite-enhancing properties of cannabinoids, Artelo Biosciences is currently developing…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.